Graft Polymer UK PLC
LSE:GPL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Graft Polymer UK PLC
Net Income (Common)
Graft Polymer UK PLC
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Graft Polymer UK PLC
LSE:GPL
|
Net Income (Common)
-£3.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson Matthey PLC
LSE:JMAT
|
Net Income (Common)
-£129m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Croda International PLC
LSE:CRDA
|
Net Income (Common)
£62m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Victrex PLC
LSE:VCT
|
Net Income (Common)
£27.8m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
|
Elementis PLC
LSE:ELM
|
Net Income (Common)
-$45.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Treatt PLC
LSE:TET
|
Net Income (Common)
£5.1m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-2%
|
|
Graft Polymer UK PLC
Glance View
Graft Polymer (UK) Ltd. is a holding company, which comprises polymer modification and drug delivery systems developments. The firm's primary business comprises polymer modification and drug delivery systems developments. The company develops range of products, including grafted polymer modifiers; nano-structured and crosslinking polymer alloys; and a variety of delivery vehicles for pharma and bio applications. Its products fall into the category of standard products, such as Polypropylene-based composites, Polyamide-based composites, and other composites; custom made products; and innovative products, such as GRAFTALLOY, GRAFTAKIT, GRAFTAMER TRC, and GRAFTAMER VTR. The firm provides three main types of modification solutions, including Graft/Block copolymers, Polymeric Nano-Structured Alloys and Crosslinking Master batches.
See Also
What is Graft Polymer UK PLC's Net Income (Common)?
Net Income (Common)
-3.1m
GBP
Based on the financial report for Dec 31, 2023, Graft Polymer UK PLC's Net Income (Common) amounts to -3.1m GBP.
What is Graft Polymer UK PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-15%
Over the last year, the Net Income (Common) growth was -15%.
